Références
Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn’s disease. Gastroenterology. 2006;130:650–6.
Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, et al. SONIC study group. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med 2010;362:1383–95.
Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, et al. Risk factors for opportunistic infections in patients with inflammatory Bowel disease. Gastroenterology. 2008;134:929–36.
Louis E et al. Infliximab discontinuation in Crohn’s disease: a prospective study. Gastroenterology 2009;136:A961.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Bonnaud, G., Moreau, J. Les immunosuppresseurs en pratique dans les MICI. Acta Endosc 40, 347–353 (2010). https://doi.org/10.1007/s10190-010-0122-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10190-010-0122-z